These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M. J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [Abstract] [Full Text] [Related]
5. Relative risks and benefits of long-term estrogen replacement therapy: a decision analysis. Gorsky RD, Koplan JP, Peterson HB, Thacker SB. Obstet Gynecol; 1994 Feb; 83(2):161-6. PubMed ID: 8290175 [Abstract] [Full Text] [Related]
7. Benefits and risks of hormone/estrogen replacement. Thomas DJ. Nurs Clin North Am; 1996 Dec; 31(4):815-25. PubMed ID: 8969341 [Abstract] [Full Text] [Related]
8. Epidemiology and the menopause: a global overview. Barrett-Connor E. Int J Fertil Menopausal Stud; 1993 Dec; 38 Suppl 1():6-14. PubMed ID: 8499961 [Abstract] [Full Text] [Related]
9. Justification for the use of HRT in the long-term prevention of osteoporosis. Stevenson JC. Maturitas; 2005 Jun 16; 51(2):113-26. PubMed ID: 15917151 [Abstract] [Full Text] [Related]
10. Hormone replacement therapy in postmenopausal women. Prelevic GM, Kocjan T, Markou A. Minerva Endocrinol; 2005 Mar 16; 30(1):27-36. PubMed ID: 15877011 [Abstract] [Full Text] [Related]
12. [Menopause and hormone replacement therapy]. Tóth KS. Orv Hetil; 2000 Mar 12; 141(11):547-56. PubMed ID: 10741167 [Abstract] [Full Text] [Related]
13. The risks and benefits of long-term estrogen replacement therapy. Barrett-Connor EL. Public Health Rep; 1989 Mar 12; 104 Suppl(Suppl):62-5. PubMed ID: 2517703 [Abstract] [Full Text] [Related]
14. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy. Genazzani AR, Gadducci A, Gambacciani M. Climacteric; 2001 Sep 12; 4(3):181-93. PubMed ID: 11588941 [Abstract] [Full Text] [Related]
16. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)]. Martin-Du Pan RC, Luzuy F. Rev Med Suisse Romande; 2000 Jun 12; 120(6):523-7. PubMed ID: 11014097 [Abstract] [Full Text] [Related]
17. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy]. Stjernquist M, North American Menopause Society (NAMS) Advisory Panel. Lakartidningen; 2003 May 15; 100(20):1790-7. PubMed ID: 12806859 [Abstract] [Full Text] [Related]
18. Postmenopausal hormone therapy: from monkey glands to transdermal patches. Davis SR, Dinatale I, Rivera-Woll L, Davison S. J Endocrinol; 2005 May 15; 185(2):207-22. PubMed ID: 15845914 [Abstract] [Full Text] [Related]
19. Weighing the risks and benefits of hormone therapy. Toth S, Blanchard E, Herman L, Larson L, Léger MM, McNellis R, Quigley T, Van Dyke E. JAAPA; 2003 Jun 15; 16(6):45-7. PubMed ID: 14968505 [No Abstract] [Full Text] [Related]